Diversity of Participants in the 340B Drug Pricing Program for US Hospitals.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 29799997.
- Also identified by DOI 10.1001/jamainternmed.2018.2015 and PMC identifier 6143110.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study examines how uncompensated care, provision of low-profit services, and financial stability differed between nonprofit and public hospitals in the United States that were participating in the 340B drug pricing plan compared with nonparticipating hospitals in 2015.
Medical subject headings
- Costs and Cost Analysis
- Drug Costs
- Drug Industry
- Economics, Hospital